In the new trial, researchers split 104 people with type 2 diabetes into two groups: One set took increasing amounts of semaglutide on a typical, 8-week dosing program, while the other group ramped up their dose on a slower, more flexible schedule that took 16 weeks
Similar content being viewed by others Introduction Millions of children experience concussion annually 1,2
Kopetz S , Tran HT, Cunningham D, Mookerjee B, Pike L, Jurgensmeier J, Heymach J
Structural determinants of dual incretin receptor agonism by tirzepatide, Proc
Some epidemiological data indicate potential associations with reduced rates of certain obesity-related malignancies, possibly related to weight loss and improved metabolic health, though causality has not been established